View BMS Chair/CEO Caforio Keynote at Virtual 22nd Pharmaceutical & Medical Device Ethics and Compliance Congress; Video Archive Now Available in Both Online and Thumb Drive Formats
  • 6 Months Access to Video Archive Available
  • Sponsored by the Pharmaceutical Compliance Forum (PCF)
  • Featuring Invitation-only CCO Roundtable & Industry-only Best Practice Exchange Day
  • Media Partners: Harvard Health Policy Review, Health Affairs and Life Sciences Compliance Update
  • Broadcast on November 2 - 5, 2021 and Video Archived Thereafter
  • www.PharmaCongress.com

PRESS RELEASE
Phone: 800-503-7419
Email: reginfo@hcconferences.com
Website: www.PharmaCongress.com

AGENDA AVAILABLE
Click Here for Agenda.


VIEW VIDEO OF KEYNOTE INTERVIEW



KEYNOTE BY:

Giovanni Caforio, MD
Chairman and Chief Executive Officer, Bristol Myers Squibb, Princeton, NJ
INTERVIEWED BY:

Adam Dubow, JD
Senior Vice President, Chief Compliance and Ethics Officer, Bristol Myers Squibb, Princeton, NJ

WASHINGTON, DC USA -- PHARMA UPDATE NEWS SERVICE™ -- NOVEMBER 29, 2021: The video archive in either online or thumb drive format of the Twenty Second Pharmaceutical & Medical Device Ethics and Compliance Congress, a fully virtual, online event that was held on November 2 - 5, 2021, is now available.

KEYNOTE SPEAKERS

Giovanni Caforio, MD
Chairman and Chief Executive Officer, Bristol Myers Squibb, Princeton, NJ

Antoinette Gawin, MSC
President & Chief Executive Officer, Terumo BCT; Chair, AdvaMed Board Ethics & Healthcare Compliance Committee

Catherine (Katie) Gray, PharmD
Acting Director, FDA Office of Prescription Drug Promotion

Rady Johnson, JD
Executive Vice President and Chief Compliance, Quality & Risk Officer, Pfizer Inc.

Mary E. Riordan, JD
Senior Counsel, Office of Counsel to the Inspector General, Office of Inspector General, US Department of Health and Human Services

Tim Wright
Chief Executive Officer, MiMedx

Jamie Yavelberg, JD
Director, Fraud Section, Civil Division, US Department of Justice

INVITATION-ONLY CCO ROUNDTABLE
Sponsored by PCF, AdvaMed & PhRMA
Tuesday 11/2


PhRMA Update

Julie Ritchie Wagner, JD
Senior Assistant General Counsel, PhRMA
AdvaMed Update

Nancy Schwalje Travis, MA
VP, Global Compliance & Governance, AdvaMed

INDUSTRY-ONLY DAY
Closed Session for Industry Ethics & Compliance
Professionals & In-house Counsel For Dialogue on Best Practices
Friday 11/5

Featuring


Craig Carpenito, JD
Partner, King & Spalding; Former United States Attorney, District of New Jersey

THE ANNUAL CCO FIRESIDE CHAT WITH

Ann E. Beasley, JD
Chief Compliance Officer, Zai Lab

Shefali Kothari, JD
VP, CCO (US), Novartis

Angela Main, JD
SVP, Global CCO & Associate GC, Asia Pacific, Zimmer Biomet

Kristin Rand, JD, MA
Head, Corporate Compliance and Global Risk Officer, Moderna

Latarsha Stewart, JD, MS
VP, Head of Compliance, Servier Pharmaceuticals

Tom Gregory, MBA
Global & US Leader, Health & Life Sciences, Forensic & Integrity Services, EY (Moderator)

AUSA ROUNDTABLE


Matthew J. Lash, JD
Trial Attorney, Consumer Protection Branch, Civil Division, US Department of Justice


Abraham George, JD
Assistant US Attorney, US Attorney's Office, District of Massachusetts, US Department of Justice


Nicholas Grippo, JD
Chief, Criminal Division, US Attorney's Office, District of New Jersey, US Department of Justice


John T. Bentivoglio, JD
Partner, Skadden Arps LLP (Moderator)

PCF EXECUTIVE COMMITTEE

Joe Zimmerman
Vice President, Chief Compliance Officer & Privacy Officer, Ferring Pharmaceuticals, Inc., Parsippany, NJ
(PCF Chair)
"We consulted with our membership and the majority recommended that we hold the Congress again in 2021 as a purely virtual event. Some of our member companies have still not allowed in-person attendance at conferences. Barring unexpected developments, we are currently planning to return to the hybrid model in 2022 which will offer registrants the option of participation onsite or online."

- PCF Executive Committee

Indrani Franchini, JD
Executive Vice President Chief Compliance Officer, Alexion Pharmaceuticals, New York, NY
(PCF Co-Chair)

Joshua Marks, JD
Vice President, Chief Ethics & Compliance Officer, Boehringer Ingelheim, Ridgefield, CT
(PCF Co-Chair)

Margaret Sparks, JD
Head of Compliance, Vaccines, North America Ethics and Business Integrity, Sanofi, Bridgewater, NJ
(PCF Co-Chair)

Ann-Marie Tejcek, MA
Senior Director, Chief Compliance Officer North America, Eli Lilly, Indianapolis, IN
(PCF Co-Chair)

Donna White, CCEP
Vice President, Compliance, Chiesi, USA, Cary, NC
(PCF Co-Chair)

MEDICAL DEVICE STEERING COMMITTEE

Sujata Dayal, JD
Vice President & Global Chief Compliance Officer, Medline Industries, Inc.

Ethan Gumpert
Global Ethics, Compliance & Governance, Advanced Medical Technology Association (AdvaMed)

Daniel Spicehandler, JD
Vice President Compliance- Commercial Divisions, Stryker

For the full list of faculty, click here

SPONSORED BY
The Pharmaceutical Compliance Forum (PCF) is a coalition of compliance professionals including compliance officers and senior legal counsels from 85+ distinguished researched-based pharmaceutical manufacturers and biotech companies. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effect corporate compliance programs.

GRANTORS
GOLD


SILVER


BRONZE
Sponsor of Pharma Congress































MEDIA PARTNERS







FEATURING THE PHARMA & MEDICAL DEVICE CONGRESS ADVANCED VIRTUAL INTERACTIVE VIDEO BROADCAST PORTAL
Featuring one-on-one attendee video chat and large group video interactive workshops.

See last year's Congress portal:




CONGRESS REGISTRATION
For Congress registration information, visit https://www.pharmacongress.com/registration-webinar/, email reginfo@hcconferences.com, or call 800-503-7419.

CONGRESS EXHIBIT & SPONSORSHIP INFORMATION
For sponsorship and exhibit information contact Suzanne Tyler, Exhibit Manager, at (206) 244-4861 phone, (206) 319-5303 fax, or exhibits@hcconferences.com.

FOR E-MAIL ADDRESS CHANGE, ADD OR DELETE REQUESTS
For changes or additions, please email your request to: listmgr@PharmaUpdateNewsService.com.

For removal of your e-mail address, please click the link below for "SafeUnsubscribe" to automatically remove your address from the list.